A soluble hexameric form of CD40 ligand activates human dendritic cells and augments memory T cell response

Vaccine

Volumn 26, Issue 32, 2008, Pages 4006-4014

  Miconnet, Isabelle ^a   Pantaleo, Giuseppe ^a  

^a Laboratory of AIDS Immunopathogenesis   (Switzerland)

Author keywords

Adjuvant; Dendritic cells; Memory T cells

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND; CD86 ANTIGEN; GAMMA INTERFERON; GLYCOPROTEIN P 15095; HLA DR ANTIGEN; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNOGENICITY; IMMUNOMODULATION; IMMUNOSTIMULATION; MEMORY T LYMPHOCYTE; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VACCINE PRODUCTION;

CD40 LIGAND; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CELL PROLIFERATION; CYTOKINES; DENDRITIC CELLS; HUMANS; IMMUNOLOGIC MEMORY; LEUKOCYTES, MONONUCLEAR; SILVER; T-LYMPHOCYTES, CYTOTOXIC;

EID: 47349124305     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.05.028     Document Type: Article

References (51)

1. Akira S., Uematsu S., and Takeuchi O. Pathogen recognition and innate immunity. Cell 124 4 (2006) 783-801
2. Meylan E., Tschopp J., and Karin M. Intracellular pattern recognition receptors in the host response. Nature 442 7098 (2006) 39-44
3. Iwasaki A., and Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nature Immunology 5 10 (2004) 987-995
4. Janssen E.M., Lemmens E.E., Wolfe T., Christen U., von Herrath M.G., and Schoenberger S.P. CD4 + T cells are required for secondary expansion and memory in CD8 + T lymphocytes. Nature 421 6925 (2003) 852-856
5. Shedlock D.J., and Shen H. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 300 5617 (2003) 337-339 (see comment)
6. Sun J.C., and Bevan M.J. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 300 5617 (2003) 339-342 (see comment)
7. Bennett S.R., Carbone F.R., Karamalis F., Flavell R.A., Miller J.F., and Heath W.R. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393 6684 (1998) 478-480 (see comment)
8. Ridge J.P., Di Rosa F., and Matzinger P. A conditioned dendritic cell can be a temporal bridge between a CD4 + T-helper and a T-killer cell. Nature 393 6684 (1998) 474-478 (see comment)
9. Schoenberger S.P., Toes R.E., van der Voort E.I., Offringa R., and Melief C.J. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393 6684 (1998) 480-483 (see comment)
10. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., et al. Immunobiology of dendritic cells. Annual Review of Immunology 18 (2000) 767-811
11. Zammit D.J., Cauley L.S., Pham Q.M., and Lefrancois L. Dendritic cells maximize the memory CD8 T cell response to infection. Immunity 22 5 (2005) 561-570
12. MacLeod M., Kwakkenbos M.J., Crawford A., Brown S., Stockinger B., Schepers K., et al. CD4 memory T cells survive and proliferate but fail to differentiate in the absence of CD40. Journal of Experimental Medicine 203 4 (2006) 897-906
13. Diehl L., den Boer A.T., Schoenberger S.P., van der Voort E.I., Schumacher T.N., Melief C.J., et al. CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy. Nature Medicine 5 7 (1999) 774-779
14. French R.R., Chan H.T., Tutt A.L., and Glennie M.J. CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help. Nature Medicine 5 5 (1999) 548-553
15. Sotomayor E.M., Borrello I., Tubb E., Rattis F.M., Bien H., Lu Z., et al. Conversion of tumor-specific CD4 + T-cell tolerance to T-cell priming through in vivo ligation of CD40. Nature Medicine 5 7 (1999) 780-787
16. van Mierlo G.J., den Boer A.T., Medema J.P., van der Voort E.I., Fransen M.F., Offringa R., et al. CD40 stimulation leads to effective therapy of CD40(-) tumors through induction of strong systemic cytotoxic T lymphocyte immunity. Proceedings of the National Academy of Sciences of the United States of America 99 8 (2002) 5561-5566
17. van Mierlo G.J., Boonman Z.F., Dumortier H.M., den Boer A.T., Fransen M.F., Nouta J., et al. Activation of dendritic cells that cross-present tumor-derived antigen licenses CD8 + CTL to cause tumor eradication. Journal of Immunology 173 11 (2004) 6753-6759
18. Kedl R.M., Jordan M., Potter T., Kappler J., Marrack P., and Dow S. CD40 stimulation accelerates deletion of tumor-specific CD8(+) T cells in the absence of tumor-antigen vaccination. Proceedings of the National Academy of Sciences of the United States of America 98 19 (2001) 10811-10816
19. Barr T.A., McCormick A.L., Carlring J., and Heath A.W. A potent adjuvant effect of CD40 antibody attached to antigen. Immunology 109 1 (2003) 87-92
20. Ahonen C.L., Doxsee C.L., McGurran S.M., Riter T.R., Wade W.F., Barth R.J., et al. Combined TLR and CD40 triggering induces potent CD8 + T cell expansion with variable dependence on type I IFN. Journal of Experimental Medicine 199 6 (2004) 775-784
21. Welters M.J., Bijker M.S., van den Eeden S.J., Franken K.L., Melief C.J., Offringa R., et al. Multiple CD4 and CD8 T-cell activation parameters predict vaccine efficacy in vivo mediated by individual DC-activating agonists. Vaccine 25 8 (2007) 1379-1389
22. Vonderheide R.H., Flaherty K.T., Khalil M., Stumacher M.S., Bajor D.L., Hutnick N.A., et al. Clinical activity and immune modulation in cancer patients treated with CP-870,893, a novel CD40 agonist monoclonal antibody. Journal of Clinical Oncology 25 7 (2007) 876-883
23. Morris A.E., Remmele Jr. R.L., Klinke R., Macduff B.M., Fanslow W.C., and Armitage R.J. Incorporation of an isoleucine zipper motif enhances the biological activity of soluble CD40L (CD154). Journal of Biological Chemistry 274 1 (1999) 418-423
24. Vonderheide R.H., Dutcher J.P., Anderson J.E., Eckhardt S.G., Stephans K.F., Razvillas B., et al. Phase I study of recombinant human CD40 ligand in cancer patients. Journal of Clinical Oncology 19 13 (2001) 3280-3287 (see comment)
25. Holler N., Tardivel A., Kovacsovics-Bankowski M., Hertig S., Gaide O., Martinon F., et al. Two adjacent trimeric Fas ligands are required for Fas signaling and formation of a death-inducing signaling complex. Molecular & Cellular Biology 23 4 (2003) 1428-1440
26. Haswell L.E., Glennie M.J., and Al-Shamkhani A. Analysis of the oligomeric requirement for signaling by CD40 using soluble multimeric forms of its ligand CD154. European Journal of Immunology 31 10 (2001) 3094-3100
27. Stone G.W., Barzee S., Snarsky V., Kee K., Spina C.A., Yu X.F., et al. Multimeric soluble CD40 ligand and GITR ligand as adjuvants for human immunodeficiency virus DNA vaccines. Journal of Virology 80 4 (2006) 1762-1772
28. Romani N., Reider D., Heuer M., Ebner S., Kampgen E., Eibl B., et al. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. Journal of Immunological Methods 196 2 (1996) 137-151
29. de Goer de Herve M.G., Durali D., Tran T.A., Maigne G., Simonetta F., Leclerc P., et al. Differential effect of agonistic anti-CD40 on human mature and immature dendritic cells: the Janus face of anti-CD40. Blood 106 8 (2005) 2806-2814
30. Arens R., Schepers K., Nolte M.A., van Oosterwijk M.F., van Lier R.A., Schumacher T.N., et al. Tumor rejection induced by CD70-mediated quantitative and qualitative effects on effector CD8 + T cell formation. Journal of Experimental Medicine 199 11 (2004) 1595-1605
31. Taraban V.Y., Rowley T.F., and Al-Shamkhani A. Cutting edge: a critical role for CD70 in CD8 T cell priming by CD40-licensed APCs. Journal of Immunology 173 11 (2004) 6542-6546
32. Bullock T.N., and Yagita H. Induction of CD70 on dendritic cells through CD40 or TLR stimulation contributes to the development of CD8 + T cell responses in the absence of CD4 + T cells. Journal of Immunology 174 2 (2005) 710-717
33. Sanchez P.J., McWilliams J.A., Haluszczak C., Yagita H., and Kedl R.M. Combined TLR/CD40 stimulation mediates potent cellular immunity by regulating dendritic cell expression of CD70 in vivo. Journal of Immunology 178 3 (2007) 1564-1572
34. Borst J., Hendriks J., and Xiao Y. CD27 and CD70 in T cell and B cell activation. Current Opinion in Immunology 17 3 (2005) 275-281
35. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nature Reviews Immunology 3 2 (2003) 133-146
36. Curtsinger J.M., Lins D.C., and Mescher M.F. Signal 3 determines tolerance versus full activation of naive CD8 T cells: dissociating proliferation and development of effector function. Journal of Experimental Medicine 197 9 (2003) 1141-1151
37. Schulz O., Edwards A.D., Schito M., Aliberti J., Manickasingham S., Sher A., et al. CD40 triggering of heterodimeric IL-12 p70 production by dendritic cells in vivo requires a microbial priming signal. Immunity 13 4 (2000) 453-462
38. Sallusto F., and Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. Journal of Experimental Medicine 179 4 (1994) 1109-1118
39. Harari A., Dutoit V., Cellerai C., Bart P.A., Du Pasquier R.A., and Pantaleo G. Functional signatures of protective antiviral T-cell immunity in human virus infections. Immunological Reviews 211 (2006) 236-254
40. Harari A., Vallelian F., Meylan P.R., and Pantaleo G. Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence. Journal of Immunology 174 2 (2005) 1037-1045
41. Caux C., Massacrier C., Vanbervliet B., Dubois B., Van Kooten C., Durand I., et al. Activation of human dendritic cells through CD40 cross-linking. Journal of Experimental Medicine 180 4 (1994) 1263-1272
42. Cella M., Scheidegger D., Palmer-Lehmann K., Lane P., Lanzavecchia A., and Alber G. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. Journal of Experimental Medicine 184 2 (1996) 747-752
43. Rissoan M.C., Soumelis V., Kadowaki N., Grouard G., Briere F., de Waal Malefyt R., et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science 283 5405 (1999) 1183-1186 (see comment)
44. Ochsenbein A.F., Riddell S.R., Brown M., Corey L., Baerlocher G.M., Lansdorp P.M., et al. CD27 expression promotes long-term survival of functional effector-memory CD8 + cytotoxic T lymphocytes in HIV-infected patients. Journal of Experimental Medicine 200 11 (2004) 1407-1417
45. Powell Jr. D.J., Dudley M.E., Robbins P.F., and Rosenberg S.A. Transition of late-stage effector T cells to CD27 + CD28 + tumor-reactive effector memory T cells in humans after adoptive cell transfer therapy. Blood 105 1 (2005) 241-250
46. Herr W., Ranieri E., Olson W., Zarour H., Gesualdo L., and Storkus W.J. Mature dendritic cells pulsed with freeze-thaw cell lysates define an effective in vitro vaccine designed to elicit EBV-specific CD4(+) and CD8(+) T lymphocyte responses. Blood 96 5 (2000) 1857-1864
47. Albert M.L., Jegathesan M., and Darnell R.B. Dendritic cell maturation is required for the cross-tolerization of CD8 + T cells. Nature Immunology 2 11 (2001) 1010-1017 (see comment)
48. Blachere N.E., Morris H.K., Braun D., Saklani H., Di Santo J.P., Darnell R.B., et al. IL-2 is required for the activation of memory CD8 + T cells via antigen cross-presentation. Journal of Immunology 176 12 (2006) 7288-7300
49. Pierre P., Turley S.J., Gatti E., Hull M., Meltzer J., Mirza A., et al. Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 388 6644 (1997) 787-792 (see comment)
50. Delamarre L., Holcombe H., and Mellman I. Presentation of exogenous antigens on major histocompatibility complex (MHC) class I and MHC class II molecules is differentially regulated during dendritic cell maturation. Journal of Experimental Medicine 198 1 (2003) 111-122
51. Bourgeois C., Rocha B., and Tanchot C. A role for CD40 expression on CD8 + T cells in the generation of CD8 + T cell memory. Science 297 5589 (2002) 2060-2063